It kind of feels inevitable in America, but Goldman Sachs analysts questioned the wisdom of using gene therapy to cure people - because that cuts off pharmaceut

It kind of feels inevitable in America, but Goldman Sachs analysts questioned the wisdom of using gene therapy to cure people - because that cuts off pharmaceutical companies from a steady income stream keeping them alive through selling them drugs. https://www.cnbc.com/2018/04/11/goldman-asks-is-curing-patients-a-sustainable-business-model.html https://www.cnbc.com/2018/04/11/goldman-asks-is-curing-patie...